Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06624475 |
| Title | Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma (NEON) |
| Acronym | NEON |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of California, San Diego |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, Irvine | RECRUITING | Irvine | California | 92868 | United States | Details |
| University of California, San Diego Moores Cancer Center | RECRUITING | La Jolla | California | 92093 | United States | Details |
| University of California, San Francisco | RECRUITING | San Francisco | California | 94158 | United States | Details |